The Progress of Chitosan-Based Nanoparticles for Intravesical Bladder Cancer Treatment

Bladder cancer (BC) is the most frequently occurring cancer of the urinary system, with non-muscle-invasive bladder cancer (NMIBC) accounting for 75–85% of all the bladder cancers. Patients with NMIBC have a good survival rate but are at high risk for tumor recurrence and disease progression. Intrav...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Chong, Wang, Shuai, Lai, Wing-Fu, Zhang, Dahong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861699/
https://www.ncbi.nlm.nih.gov/pubmed/36678840
http://dx.doi.org/10.3390/pharmaceutics15010211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861699/
https://www.ncbi.nlm.nih.gov/pubmed/36678840
http://dx.doi.org/10.3390/pharmaceutics15010211

Ejemplares similares